Comparison of early myocardial technetium-99m pyrophosphate uptake to early peaking of creatine kinase and creatine kinase-MB as indicators of early reperfusion in acute myocardial infarction

Am J Cardiol. 1987 Oct 1;60(10):762-5. doi: 10.1016/0002-9149(87)91019-8.

Abstract

The value of technetium-99m pyrophosphate (Tc-99m-PYP) scintigraphy as an indicator of reperfusion 2.8 to 8 hours after the onset of symptoms of acute myocardial infarction was compared with the value of early peak creatine kinase (CK) and CK-MB release within 16 hours after the onset of symptoms. In 29 patients who received thrombolytic therapy, recanalization was seen (group 1) and in 7 it was not (group 2). In 23 patients (79%) in group 1 scintigraphic findings were positive and in all 7 in group 2 they were negative. In 15 patients (52%) in group 1 and 1 patient (14%) in group 2, CK reached its peak level within 16 hours. In 20 patients (69%) in group 1 and 3 (43%) in group 2 the CK-MB level reached a peak within 16 hours. The sensitivity, specificity and predictive accuracy of positive results of early Tc-99m-PYP scintigraphy in predicting the reperfusion were 79%, 100% and 83%. These values are significantly higher than or similar to those of early peaking of CK and CK-MB release. In contrast to measurements of enzyme release, reperfusion data for Tc-99m-PYP scintigraphy are available immediately after thrombolytic therapy. Therefore, early Tc-99m-PYP scintigraphy (3 to 8 hours after onset of symptoms) is valuable as a noninvasive technique for early diagnosis of reperfusion.

MeSH terms

  • Aged
  • Angiocardiography
  • Cineangiography
  • Coronary Angiography
  • Creatine Kinase / blood*
  • Diphosphates*
  • Female
  • Heart / diagnostic imaging
  • Humans
  • Isoenzymes
  • Male
  • Middle Aged
  • Myocardial Infarction / diagnostic imaging
  • Myocardial Infarction / drug therapy
  • Myocardial Infarction / enzymology*
  • Myocardium / enzymology*
  • Radionuclide Imaging
  • Technetium Tc 99m Pyrophosphate
  • Technetium*
  • Urokinase-Type Plasminogen Activator / therapeutic use*

Substances

  • Diphosphates
  • Isoenzymes
  • Technetium Tc 99m Pyrophosphate
  • Technetium
  • Creatine Kinase
  • Urokinase-Type Plasminogen Activator